SYZYGIUM JAMBOLANUM (HOMEOLAB USA INC.)
Welcome to the PulseAid listing for the SYZYGIUM JAMBOLANUM drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | HOMEOLAB USA INC. |
NON-PROPRIETARY NAME: | SYZYGIUM JAMBOLANUM |
SUBSTANCE NAME: | SYZYGIUM JAMBOS SEED |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 1995-10-11 |
END MARKETING DATE: | 0000-00-00 |
SYZYGIUM JAMBOLANUM HUMAN OTC DRUG Details:
Item Description | SYZYGIUM JAMBOLANUM from HOMEOLAB USA INC. |
LABELER NAME: | HOMEOLAB USA INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3([hp_X]/1) |
START MARKETING DATE: | 1995-10-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60512-6997_2880f07e-526d-409b-8cbd-3dad8561ca5c |
PRODUCT NDC: | 60512-6997 |
APPLICATION NUMBER: | |
Other SYZYGIUM JAMBOS SEED Pharmaceutical Manufacturers / Labelers: